Premium
Treatment of Status Migrainosus: The American Experience
Author(s) -
Raskin Nell H.
Publication year - 1990
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.1990.hed30s2550.x
Subject(s) - ergotamine , dihydroergotamine , migraine , dosing , medicine , mechanism (biology) , intensive care medicine , anesthesia , pharmacology , philosophy , epistemology
SYNOPSIS Dependence upon a variety of drugs ‐ ergotamine, analgesics, benzodiazepines, corticosteroids ‐is a major reason for patients to enter an intractable phase of their migrainous disorders. Repeated dosing of dihydroergotamine has proven to be remarkably effective in stabilizing the mechanism of migraine, allowing these patients to make the transition to a more reasonable as well as more specific form of therapy.